TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 3.00E+3nMAssay Description:Inhibition of recombinant full lenght human PDE8A using fluorescent labeled cAMP as substrate after 15 mins by IMAP assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 8.20E+3nMAssay Description:Inhibition of recombinant full lenght human PDE8A using fluorescent labeled cAMP as substrate after 15 mins by IMAP assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]cAMP from PDE8A1 by competitive binding assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]cAMP from PDE8A1 by competitive binding assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]cAMP from PDE8A1 by competitive binding assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]cAMP from PDE8A1 by competitive binding assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]cAMP from PDE8A1 by competitive binding assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]cAMP from PDE8A1 by competitive binding assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]cAMP from PDE8A1 by competitive binding assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 3.30E+4nMAssay Description:Inhibition of recombinant full lenght human PDE8A using fluorescent labeled cAMP as substrate after 15 mins by IMAP assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: 5.40E+4nMAssay Description:Inhibition of recombinant full lenght human PDE8A using fluorescent labeled cAMP as substrate after 15 mins by IMAP assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataKi: >1.00E+5nMAssay Description:Inhibition of recombinant full lenght human PDE8A using fluorescent labeled cAMP as substrate after 15 mins by IMAP assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Antagonist activity at human EP1 receptor expressed in CHO cells receptor by NFTA reporter gene assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Antagonistic affinity tested against isolated Rat Spleen Alpha-1B adrenergic receptorMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 0.700nMAssay Description:Inhibition of PDE8A (unknown origin)More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 15nMpH: 7.5Assay Description:By using for PDE8 an enzymatic assay equivalent to that described for PDE7. PDE7 Enzymatic Assay: The assay is carried out in 1.5 ml Eppendorf tube...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 140nMpH: 7.5Assay Description:By using for PDE8 an enzymatic assay equivalent to that described for PDE7. PDE7 Enzymatic Assay: The assay is carried out in 1.5 ml Eppendorf tube...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 194nMAssay Description:Inhibition of recombinant PDE8A1 (480 to 828 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]cAMP as substrate incubated for ...More data for this Ligand-Target Pair
Ligand InfoPDB
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 220nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 240nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 280nMAssay Description:Antagonistic affinity tested against isolated Rat Thoracic Aorta Alpha-1D adrenergic receptorMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 360nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 390nMpH: 7.5Assay Description:By using for PDE8 an enzymatic assay equivalent to that described for PDE7. PDE7 Enzymatic Assay: The assay is carried out in 1.5 ml Eppendorf tube...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 410nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >500nMAssay Description:Inhibition of recombinant human PDE8A using [3H]cAMP after 1 hr by scintillation proximity assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 500nMpH: 7.5 T: 24°CAssay Description:Enzymatic activities were assayed using [3H] cAMP and [3H]cGMP as substrate.More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 660nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 710nMAssay Description:Inhibition of PDE8A1 (480-828) (unknown origin) expressed in Escherichia coli BL21 assessed as using [3H]-cAMP as substrate measured for 15 mins by l...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 820nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: 920nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H]-cAMP substrate incubated for 15 mins by liq...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of PDE8aMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of recombinant human PDE8A using [3H]cAMP after 1 hr by scintillation proximity assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of recombinant human PDE8A using [3H]cAMP after 1 hr by scintillation proximity assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of recombinant human PDE8A using [3H]cAMP after 1 hr by scintillation proximity assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of recombinant human PDE8A using [3H]cAMP after 1 hr by scintillation proximity assayMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of human recombinant PDE8AMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:Inhibition of PDE8AMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >2.00E+3nMAssay Description:Inhibition of PDE8AMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >2.00E+3nMAssay Description:Inhibition of PDE8AMore data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
Intra-Cellular Therapies
Curated by ChEMBL
Intra-Cellular Therapies
Curated by ChEMBL
Affinity DataIC50: >2.00E+3nMAssay Description:Inhibition of PDE8AMore data for this Ligand-Target Pair